Regeneron COVID-19 antibody therapy cuts death risk in hospitalized patients lacking immune response
Regeneron’s COVID-19 therapy was found to reduce the risk of death in hospitalized patients who had not mounted their own immune response to the virus by up to 20%, the company said Wednesday
CDC panel to discuss COVID-19 vaccination, rare heart issues
Reports of heart inflammation among a small fraction of Pfizer and Moderna COVID-19 vaccine recipients, predominantly males under 30, are under review as an advisory panel to the Centers for Disease Control and Prevention is set to meet Friday.
New York lifts remaining COVID-19 restrictions after reaching vaccination goal
New York Gov. Andrew Cuomo announced Tuesday that all remaining COVID-19 restrictions "would be relaxed as of today" after the state reached its goal of vaccinating 70% of the adult population, but mask-wearing would remain in effect for some.
US coronavirus deaths hit 600,000 as weekly fatalities decline to new lows
The U.S. recorded a grim milestone Tuesday with over 600,000 deaths attributed to coronavirus, according to data from Johns Hopkins University. However, the news comes as weekly fatalities have declined to lows not seen since early on in the pandemic.
Delta COVID-19 variant doubles risk of hospitalization compared to Alpha strain, Scottish study finds
A study out of Scotland has found the Delta COVID-19 variant carries double the risk of hospitalization compared to the Alpha strain, particularly in patients with five or more comorbidities.
UK to face ‘substantial third wave’ of coronavirus as Delta variant spreads, expert says
A top expert with the U.K.’s Scientific Advisory Group for Emergencies (SAGE) on Sunday warned the region is approaching a third wave of COVID-19 infections as a highly transmissible variant first detected in India continues to proliferate.